ABILIFY — Class II drug recall D-181-2013
Terminated recall by Bristol Myers Squibb Manufacturing Company, reported 2013-03-13, distributed in CA, LA, TN. CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from
| Recall number | D-181-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bristol Myers Squibb Manufacturing Company, Humacao, PR, United States |
| Recall initiated | 2012-11-02 |
| Classified | 2013-03-04 |
| Reported by FDA | 2013-03-13 |
| Terminated | 2013-05-02 |
| Distributed | CA, LA, TN |
| Quantity | 21 blister |
| Reason classes | cgmp |
| NDC | 59148-0006, 59148-0006-13, 59148-0006-92, 59148-0007, 59148-0007-13, 59148-0007-35, 59148-0007-94, 59148-0008, 59148-0008-13, 59148-0008-35, 59148-0008-95, 59148-0009, 59148-0009-13, 59148-0009-35, 59148-0009-95, 59148-0010, 59148-0010-13, 59148-0010-35, 59148-0011, 59148-0011-13, 59148-0011-35 |
| Expiration dates | 2015-02-28 |
Product
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Reason for recall
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-181-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.